The Ongoing Shortage of Amoxicillin
- Keligne Mutambayi
- Dec 14, 2022
- 2 min read

To date, Canada continues to face an ongoing shortage of medicine. Though the effects of these shortages can be seen across various children’s medications, the limited availability of select antibiotics remains particularly concerning. Amoxicillin is one antibiotic whose shortage has engendered notable concern among Canadian health officials and the general Canadian population.
Among children, amoxicillin is the most prescribed antibiotic. Though the medication is efficacious in treating various bacterial infections, it is often administered in primary care settings to treat middle ear infections, strep throat, and chest infections like pneumonia.
Due to the resurgence of a post-COVID-19 global supply chain disruption, the shortage of amoxicillin first emerged in late 2020. In response to the shortage, the Canadian government has been working to acquire additional supplies of amoxicillin and other penicillin antibiotics. Moreover, they have also been taking steps to ensure that the supply of other similar antibiotics is not affected by the shortage. An example of this can be seen in the increased cooperation between health officials and manufacturers to increase the production of other antibiotics, such as penicillin G, that can be used as alternatives to amoxicillin.
In addition to the government’s efforts, other organizations, such as the Canadian Pharmacists Association, have been working to mitigate the effects of the amoxicillin shortage. These organizations have been providing information and guidance to pharmacists and other healthcare professionals on managing the shortage and ensuring that patients continue to have access to the antibiotics they need.
In conclusion, the shortage of amoxicillin in Canada is a significant issue affecting the healthcare system and the general population as a whole. The Canadian government, healthcare organizations, and medical professionals are working together to address the shortage and ensure that patients continue to have access to these antibiotics. In the meantime, patients are encouraged to speak with their healthcare providers about alternative treatment options if amoxicillin is not available. These alternatives may include other antibiotics, like the aforementioned penicillin G, or non-antibiotic treatments that have proven to be efficacious in treating specific conditions, such as ear infections or strep throat.
Ultimately, it is the responsibility of all of us to stay informed about the latest developments related to the shortage as, together, we can work to mitigate its effects and ensure that everyone has access to the medicine they need.
References
https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/MedSask_CPhA_Amoxicillin_Final-EN.pdf
Image from: https://s.wsj.net/public/resources/images/BN-PW628_ANTIBI_J_20160919095705.jpg



Comments